Acadia Healthcare Company Inc (NASDAQ:ACHC) currently has a daily average trading volume of 2.81M but it saw 1584016 shares traded in last market. With a market cap of 2.12B USD, the company’s current market price of $22.96 came falling about -2.34 while comparing to the previous closing price of $23.51. In past 52 weeks, the stock remained buoying in the range of price level as high as $82.40 and as low as $20.36.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Barclays which downgraded the stock as “Equal Weight” in its note to investors issued on February 28, 2025, recommending a price target of between $43 and $35 for it. KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on January 07, 2025 while assigning a price target of $70. Deutsche Bank issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $45 and $75.
Over the week, ACHC’s stock price is moving -10.45% down while it is 8.30% when we observe its performance for the past one month. Year-to-date it is -42.09% down and over the past year, the stock is showing a downside performance of -65.62%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0.7 while estimate for next year EPS is 2.62. In next quarter, company is expected to be making quarterly sales of $878.22M as analysts are expecting the sales for current fiscal year at $3.34B and seeing the company making $3.62B in sales next year. Moreover, analysts are in estimates of $838.93M for current-quarter revenue.
Currently, Acadia Healthcare Company Inc’s total number of outstanding shares is 90.39M with 1.67% of that held by the insiders while 110.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 3.52% and return on equity (ROE) at 6.35%. It has a price to earnings ratio (P/E ratio) of 11.27 while having a 7.69 of forward P/E ratio. Stock’s beta reads 0.96. Stock has a price to book (P/B) ratio of 0.68 while price to sale or P/S ratio amounts to 0.67. Its return on asset (ROA) is 3.22% on average.
